• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Rodney B. Nelson, MD
Chicago

Arch Intern Med. 1979;139(9):1063.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Systemic manifestations of hepatoma include hypoglycemia, erythrocytosis, and hypercalcemia, among others.¹ Mildly elevated levels of thyroxine-binding globulin (TBG) have been recognized in a minority of patients with hepatoma.² The case described herein demonstrates that increased TBG activity in hepatoma may lead to extreme elevation of circulating thyroid hormone in a clinically euthyroid patient. Because fever, weight loss, hypercalcemia, and other manifestations of hyperthyroidism can be seen due to hepatoma, the finding of a markedly elevated serum thyroxine (T₄) or triiodothyronine (T₃)

level must be interpreted carefully in patients with hepatoma.

Report of a Case.—

A 52-year-old woman consulted her physician because of anorexia, weight loss, and an enlarging epigastric mass. She had not noted changes in hair, skin, or bowel habit. She had no past history of thyroid disease and serum T₄ level was normal five years previously. She denied the use . . . [Full Text PDF of this Article]

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?